Is Exelixis, Inc. (EXEL) Going To Burn These Hedge Funds ?
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Posts Tagged ‘NASDAQ:EXEL’
Hedge Fund and Insider Trading News: George Soros, Per Johansson, Neil Woodford, Highfields Capital, Exelixis, Inc. (EXEL), J.Jill Inc (JILL), and More
BERLIN (Reuters) - George Soros’s Open Society Foundations, best known for funding civil rights activists across Eastern Europe and the developing world, are increasingly turning...
Here’s What Hedge Funds Think About Exelixis, Inc. (EXEL)
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due to a low interest rate environment...
Did Hedge Funds Drop The Ball On Exelixis, Inc. (EXEL) ?
Does Exelixis, Inc. (NASDAQ:EXEL) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund interest towards the company.
Do Hedge Funds Love Exelixis, Inc. (EXEL)?
Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money...
Exelixis, Symantec, Weight Watchers International and More: Here’s Why These Stocks Are Moving
Seeing as how several stocks are on the move due to earnings today, let's take a look at some of the more notable ones, including that of Exelixis Inc.
Hedge Fund and Insider Trading News: David Tepper, Tricadia Capital Management, Tiger Management, MongoDB Inc. (MDB), Infusystem Holdings Inc (INFU), Cullen/Frost Bankers, Inc. (CFR), and More
Billionaire hedge fund manager David Tepper has reached a deal to buy the Carolina Panthers, the National Football League team announced Wednesday.
Billionaire Fund Managers Are Bullish On These Biotech Stocks
The biotech sector is well known for its M&A activity, but billionaire fund managers don’t seem to be attracted by the frenzy.
Financial Markets Snapshot: 35 Fresh Stories Telling How is it Going in the Finance World Today
"U.S. equities traded higher on Friday as concerns about Donald Trump's presidency recede for the time being.
Should You Buy Exelixis, Inc. (EXEL)?
The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines.
The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3
Baker Bros. Advisors has arguably been the most successful healthcare-focused hedge fund on the Street in recent years.
This Biotech Hedge Fund’s Stock Picks Killed It in Q3
Hedge funds returned about 4% so far this year and underperformed the S&P 500 Index again.
Deere & Company (DE), Gas Natural Inc. (EGAS) & More: Why These Stocks are Trending Today
Among individual stocks that are showing more volatility today, are Deere & Company (NYSE:DE), Gas Natural Inc. (NYSEMKT:EGAS), Exelixis Inc.
Earnings Wrap: Transocean (RIG), XPO Logistics (XPO), Exelixis (EXEL), 2 More
All three index futures are pointing north in pre-market trading as the Bank of England just announced that it would cut interest rates for the first time in seven years, to ...
Facebook, CME Group Among 5 Stocks That Recently Hit 52-Week Highs
Seeing as how the S&P 500 and the Dow Jones are near record highs, it's not surprising that many stocks have recently hit 52-week highs as well.
Here’s Why These Five Stocks Are Surging Today
It's been a pretty good day on Wall Street so far as the Dow Jones Index is up almost 100 points and all three major indexes are in the green.
Pay Attention to These 5 Stocks Making Big Moves Today
The Dow Jones is slightly in the red today as market sentiment dips on a more mixed batch of earnings results being released today. Origin Agritech Ltd.
Why Are These Stocks Trading Deep in Red on Friday?
The key technical levels of 18,000 for the Dow and 2,100 for the S&P seem out of reach today as each index is in the red on the back of disappointing earnings reported by several...
Why These 5 Stocks Are Making Moves Higher Today
Wall Street has recorded moderate gains on the first day of March, with crude prices being the main catalyst for the stock exchanges. Meanwhile, there are several stocks gaining...
What Do Hedge Funds Think of Exelixis, Inc. (EXEL)?
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
Did Hedge Funds Sell Out Of Exelixis, Inc. (EXEL) Too Soon? Shares Jump On Regulatory Approval of Cobimetinib
The shares of Exelixis, Inc. (NASDAQ:EXEL) have jumped by 3.01% in today's trading session, as the company announced the first regulatory approval for Cobimetinib.
Exelixis, Inc. (EXEL) Soars Following Cancer Drug Trial Data, But Competition Looms
Shares of Exelixis, Inc.
An Excellent Investment in the Biotech Space?
According to the American Cancer Society, more than 60,000 new cases of thyroid cancer will be diagnosed in the U.S., and about 1,850 people are expected to die from the disease...
AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?
The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.
New York Community Bancorp, Inc. (NYCB), Exelixis, Inc. (EXEL): Here’s What This $53 Billion Hedge Fund Company Has Been Buying
Shaw is known as a math wizard, and a quantitative investing pioneer.
Hedge Funds Are Betting On Celldex Therapeutics, Inc. (CLDX)
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.
Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)
In today’s marketplace, there are dozens of methods market participants can use to watch the equity markets.
Is Achillion Pharmaceuticals, Inc. (ACHN) Going to Burn These Hedge Funds?
To the average investor, there are dozens of indicators market participants can use to analyze their holdings.
NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In today’s marketplace, there are tons of gauges market participants can use to track their holdings.
Exelixis, Inc. (EXEL), Vertex Pharmaceuticals Incorporated (VRTX), Celgene Corporation (CELG): Want Multibaggers? Consider These 3 Biotech Companies
In after hours trading on April 18, a few hours after the release of my previous article focusing on Exelixis, Inc.
Cytokinetics, Inc. (CYTK), Exelixis, Inc. (EXEL): Three Small Cap Biotech Stocks with Great Potential
Small cap stocks are a bit riskier, but offer more growth than the stable large cap ones. The biotech sector in U.S.
Here is What Hedge Funds Think About Puma Biotechnology Inc (PBYI)
In the eyes of most traders, hedge funds are seen as worthless, old financial tools of the past.
Is Exelixis, Inc. (EXEL) Going to Burn These Hedge Funds?
If you'd ask most investors, hedge funds are viewed as slow, old financial vehicles of yesteryear.
Do Hedge Funds and Insiders Love Celldex Therapeutics, Inc. (CLDX)?
In the financial world, there are plenty of indicators market participants can use to track publicly traded companies.
Achillion Pharmaceuticals, Inc. (ACHN): Are Hedge Funds Right About This Stock?
To most stock holders, hedge funds are seen as underperforming, old financial tools of years past.
Bristol Myers Squibb Co. (BMY), Ariad Pharmaceuticals, Inc. (ARIA): ASCO Investment Ideas
The American Society of Clinical Oncology annual meeting kicks off today.
ImmunoGen, Inc. (IMGN), AEterna Zentaris Inc. (USA) (AEZS) – Tackling Cancer: Your Best Investing Ideas
Over the past three months, we've taken a deep dive into the 12 cancer types most likely to be diagnosed in the U.S.
NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds and Insiders Are Bearish, What Should You Do?
If you'd ask most shareholders, hedge funds are assumed to be slow, outdated investment tools of the past.
Liberty Media Corp (LMCA), Sarepta Therapeutics Inc (SRPT): Here’s What This $42 Billion Hedge Fund Company Has Been Buying
Shaw is known as a math wizard, and a quantitative investing pioneer. His firm is reportedly extremely selective, hiring less than 1% of applicants -- and Amazon.com, Inc.
Chesapeake Energy Corporation (CHK), Discovery Communications Inc. (DISCA): Here’s What This $21 Billion Hedge Fund Company Has Been Buying
Today, let's look at SAC Capital Advisors, run by Steven Cohen.
SolarCity Corp (SCTY), Exelixis, Inc. (EXEL): Watch These Stocks
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
AstraZeneca plc (ADR) (AZN), Exelixis, Inc. (EXEL), Pfizer Inc. (PFE) & Tackling Cancer: Thyroid Cancer’s Biggest Current and Upcoming Players
As I noted eight weeks ago, cancer statistics are both staggering and disappointing.
Amazon.com, Inc. (AMZN), And How The Roth IRA Rules!
If you're going through life assuming that there isn't much difference between a traditional IRA and a Roth IRA, you're doing yourself a great disservice -- because the Roth IRA...
Puma Biotechnology Inc (PBYI), Achillion Pharmaceuticals, Inc. (ACHN): Here is What Hedge Funds Think About NPS Pharmaceuticals, Inc. (NPSP)
According to most investors, hedge funds are perceived as worthless, old financial tools of years past.
Exelixis, Inc. (NASDAQ:EXEL): Are Hedge Funds Right About This Stock?: Clovis Oncology Inc (CLVS), Puma Biotechnology Inc (PBYI)
Exelixis, Inc. (NASDAQ:EXEL) was in 10 hedge funds' portfolio at the end of December.
Amarin Corporation plc (ADR) (AMRN), Exelixis, Inc. (EXEL): Here’s What This 220% Gainer Has Been Buying and Selling
Today, let's look at Passport Capital, which was founded by John Burbank in 2000 and known for combining macroeconomic analysis and fundamental research.
Johnson & Johnson (JNJ), Dendreon Corporation (DNDN) – Tackling Cancer: Prostate Cancer’s Biggest Current and Upcoming Players
As I commented last week, cancer statistics are both staggering and disappointing.
Celgene Corporation (CELG)’s New Acquisition — of Celgene
Celgene Corporation (NASDAQ:CELG) announced on Wednesday a $600 million deal to buy a stake in a growing biotech with several successful products on the market and a strong pipeline...
5 Can’t-Miss Health-Care Events This Week: Dynavax Technologies Corporation (DVAX) and More
Earnings are once again going to steal the spotlight this week, with four of the five can't-miss stories in the health-care sector revolving around earnings reports.
5 Reasons to Worry About Next Week: Exelixis, Inc. (EXEL) and More
Despite the rosy State of the Union address on Tuesday, consumers are still coping with the ramifications of the end of the payroll tax stimulus that has seen take-home pay shrink...
